How do you manage severe thrombocytopenia due to splenomegaly and bone marrow involvement in CLL when starting obinituzumab and venetoclax?
Answer from: Medical Oncologist at Academic Institution
This is a tough question without any information about the case. I am assuming the patient is untreated. For this setting, there are really three options supported by randomized phase 3 trials. Venetoclax + Obinuzumab has a single randomized phase 3 trial that showed improved progression free surviv...
Comments
Medical Oncologist at Bon Secours Saint Mary's Hospital Thank you Dr. @John C. Byrd!
In this particular s...
Medical Oncologist at University of Cincinnati College of Medicine No, it does not, I would do this approach.
Thank you Dr. @John C. Byrd! In this particular s...
No, it does not, I would do this approach.